Nek2-targeted ASO or siRNA pretreatment enhances anticancer drug sensitivity in triplenegative breast cancer cells

Author: Lee Jaehyung   Gollahon Lauren  

Publisher: Spandidos Publications

ISSN: 1019-6439

Source: International Journal of Oncology, Vol.42, Iss.3, 2013-03, pp. : 839-847

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content